Jing Wu

Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes

Mark S. Schmidt, M. Pirooznia, C. Brenner, 2022, The Journal of clinical investigation.

BLOC1S1/GCN5L1/BORCS1 is a critical mediator for the initiation of autolysosomal tubulation

Xufeng Wu, Christopher K. E. Bleck, M. Sack, 2021, Autophagy.

Allele-specific mitochondrial stress induced by Multiple Mitochondrial Dysfunctions Syndrome 1 pathogenic mutations modeled in Caenorhabditis elegans

A. Golden, M. Sack, Michael Reidy, 2021, PLoS genetics.

Boosting NAD preferentially blunts Th17 inflammation via arginine biosynthesis and redox control in healthy and psoriasis subjects

S. Hassanzadeh, N. Mehta, M. Sack, 2023, Cell reports. Medicine.

Targeting NAD+ Metabolism to Modulate Autoimmunity and Inflammation.

Kim Han, Jing Wu, Michael N. Sack, 2024, Journal of immunology.

Nicotinamide Riboside Augments Human Macrophage Migration via SIRT3-Mediated Prostaglandin E2 Signaling

Rebecca D Huffstutler, Jing Wu, Allison M. Meadows, 2024, Cells.